France’s decision to criminalise the possession and use of oral nicotine pouches is facing scrutiny in Brussels, with members of the European Parliament asking the Commission to assess whether the ban breaches EU law.
The request marks the first concrete challenge to a policy that has gone further than any other in the bloc. Under rules introduced this month, France has not only banned the sale of oral nicotine pouches but made it an offence to carry or consume them—meaning a product legally bought elsewhere in the EU can trigger penalties the moment someone crosses the border.
Across much of the EU, particularly in northern member states, nicotine pouches remain legal and widely used. The same product can circulate freely under single market rules, yet become illegal the moment it enters French territory.
That shift has turned what might have been a national health measure into a wider European dispute.
The European Commission is working on a new phase of tobacco and nicotine regulation aimed at aligning rules across the bloc. The goal is to create a more consistent framework for products that move between member states.
France has taken a different approach.
By criminalising possession and use, Paris is not simply regulating a product. It is redefining what can legally exist within its territory, regardless of its status elsewhere in the Union. That creates direct tension with one of the EU’s core principles: the free movement of goods.
EU law does allow national exceptions on public health grounds. But these were designed as limited carve-outs, not sweeping prohibitions backed by criminal penalties. The scale of the French measure pushes that boundary.
Brussels now faces a difficult choice.
It presents itself as the guarantor of a unified market, yet it also leaves room for governments to act in areas such as health policy. Intervening would mean limiting national discretion. Doing nothing risks entrenching a system in which the same product is legal in one country and criminal in another.
The dispute also raises a broader question: how far the EU should be able to constrain national decisions in areas such as public health, which have traditionally remained under domestic control.
The issue is now the subject of a formal challenge in Brussels.
Paris insists the policy is aimed at protecting public health, particularly by reducing nicotine use among younger people. But the argument raises questions. Cigarettes remain legal. Vaping products are still available under regulation. The ban instead targets a category that, in other countries, is often used as an alternative to smoking.
That inconsistency suggests this is about more than nicotine.
It points to a broader shift in how regulation is evolving inside the EU. Brussels is extending its reach into areas once largely left to national governments, from health policy to consumer behaviour. At the same time, member states are testing the limits of the autonomy they still retain.
The result is growing tension at the core of the system.
The more the EU pushes for common rules, the more visible these national divergences become. Each unilateral measure forces a question the bloc has long tried to avoid: does integration mean uniform rules, or coordination between different national systems?
France has now forced that question into the open. How Brussels responds will shape not just nicotine policy, but the balance of power between national governments and the EU.
